

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine metabolic process (GO:0046087) | 9.25392178 |
| 2 | cytidine catabolic process (GO:0006216) | 9.25392178 |
| 3 | cytidine deamination (GO:0009972) | 9.25392178 |
| 4 | intestinal absorption (GO:0050892) | 7.71711782 |
| 5 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.71649760 |
| 6 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 6.64646103 |
| 7 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 6.64646103 |
| 8 | intestinal cholesterol absorption (GO:0030299) | 6.39011270 |
| 9 | sulfate transmembrane transport (GO:1902358) | 6.36758012 |
| 10 | NADH metabolic process (GO:0006734) | 6.30655682 |
| 11 | regulation of autophagic vacuole assembly (GO:2000785) | 6.08183353 |
| 12 | epoxygenase P450 pathway (GO:0019373) | 6.04579904 |
| 13 | negative regulation of macroautophagy (GO:0016242) | 5.86462620 |
| 14 | lipoprotein transport (GO:0042953) | 5.76354946 |
| 15 | negative regulation of keratinocyte proliferation (GO:0010839) | 5.74232405 |
| 16 | bile acid and bile salt transport (GO:0015721) | 5.73514605 |
| 17 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.69580714 |
| 18 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.44371991 |
| 19 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.44371991 |
| 20 | endocrine process (GO:0050886) | 5.44371991 |
| 21 | angiotensin maturation (GO:0002003) | 5.43962294 |
| 22 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.36878950 |
| 23 | sulfate transport (GO:0008272) | 5.32248441 |
| 24 | intestinal epithelial cell development (GO:0060576) | 5.05946858 |
| 25 | cellular glucuronidation (GO:0052695) | 4.91729228 |
| 26 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.86575686 |
| 27 | regulation of vacuole organization (GO:0044088) | 4.85027715 |
| 28 | cellular ketone body metabolic process (GO:0046950) | 4.84681577 |
| 29 | regulation of systemic arterial blood pressure (GO:0003073) | 4.83570498 |
| 30 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.81373085 |
| 31 | glucuronate metabolic process (GO:0019585) | 4.81087378 |
| 32 | uronic acid metabolic process (GO:0006063) | 4.81087378 |
| 33 | flavonoid metabolic process (GO:0009812) | 4.80922134 |
| 34 | alkaloid metabolic process (GO:0009820) | 4.74115547 |
| 35 | hormone catabolic process (GO:0042447) | 4.73500935 |
| 36 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.73347357 |
| 37 | fructose metabolic process (GO:0006000) | 4.71995038 |
| 38 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.71375701 |
| 39 | sulfur compound transport (GO:0072348) | 4.70708302 |
| 40 | renal system process involved in regulation of blood volume (GO:0001977) | 4.69086901 |
| 41 | diacylglycerol metabolic process (GO:0046339) | 4.67509158 |
| 42 | keratinocyte development (GO:0003334) | 4.66119367 |
| 43 | ATP synthesis coupled proton transport (GO:0015986) | 4.65241699 |
| 44 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.65241699 |
| 45 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 4.61234150 |
| 46 | regulation of cellular extravasation (GO:0002691) | 4.49502314 |
| 47 | protein neddylation (GO:0045116) | 4.49190637 |
| 48 | regulation of cGMP biosynthetic process (GO:0030826) | 4.47164091 |
| 49 | regulation of bile acid biosynthetic process (GO:0070857) | 4.43732455 |
| 50 | plasma lipoprotein particle assembly (GO:0034377) | 4.42145597 |
| 51 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 4.40529979 |
| 52 | regulation of guanylate cyclase activity (GO:0031282) | 4.38891102 |
| 53 | positive regulation of epidermal cell differentiation (GO:0045606) | 4.37976159 |
| 54 | regulation of respiratory burst (GO:0060263) | 4.37169876 |
| 55 | drug metabolic process (GO:0017144) | 4.32969307 |
| 56 | negative regulation of T cell differentiation in thymus (GO:0033085) | 4.32873168 |
| 57 | positive regulation of T cell differentiation in thymus (GO:0033089) | 4.31333444 |
| 58 | urea cycle (GO:0000050) | 4.30190023 |
| 59 | negative regulation of organelle assembly (GO:1902116) | 4.28468516 |
| 60 | negative regulation of epidermal cell differentiation (GO:0045605) | 4.26180031 |
| 61 | vitamin A metabolic process (GO:0006776) | 4.25994503 |
| 62 | positive regulation of respiratory burst (GO:0060267) | 4.24077103 |
| 63 | actin filament depolymerization (GO:0030042) | 4.18562405 |
| 64 | ketone body metabolic process (GO:1902224) | 4.17161786 |
| 65 | urea metabolic process (GO:0019627) | 4.09634747 |
| 66 | regulation of viral release from host cell (GO:1902186) | 4.09483610 |
| 67 | protein-lipid complex assembly (GO:0065005) | 4.03960907 |
| 68 | peptide hormone processing (GO:0016486) | 4.03771312 |
| 69 | drug catabolic process (GO:0042737) | 4.00008673 |
| 70 | regulation of keratinocyte proliferation (GO:0010837) | 3.97007378 |
| 71 | vitamin transmembrane transport (GO:0035461) | 3.89079123 |
| 72 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.89052228 |
| 73 | chondrocyte proliferation (GO:0035988) | 3.86126439 |
| 74 | digestive system process (GO:0022600) | 3.85982174 |
| 75 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.85954607 |
| 76 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.82153987 |
| 77 | glycosphingolipid catabolic process (GO:0046479) | 3.80981771 |
| 78 | sulfur amino acid catabolic process (GO:0000098) | 3.80957801 |
| 79 | positive regulation of pseudopodium assembly (GO:0031274) | 3.80957217 |
| 80 | mitotic G2 DNA damage checkpoint (GO:0007095) | 3.79634654 |
| 81 | antibacterial humoral response (GO:0019731) | 3.79111001 |
| 82 | glycolipid catabolic process (GO:0019377) | 3.77206936 |
| 83 | peptide catabolic process (GO:0043171) | 3.76565148 |
| 84 | nitrogen cycle metabolic process (GO:0071941) | 3.75067353 |
| 85 | cGMP-mediated signaling (GO:0019934) | 3.66975876 |
| 86 | regulation of cGMP metabolic process (GO:0030823) | 3.64173650 |
| 87 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.64167600 |
| 88 | antimicrobial humoral response (GO:0019730) | 3.62699463 |
| 89 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.61949372 |
| 90 | response to hepatocyte growth factor (GO:0035728) | 3.61949372 |
| 91 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.58111475 |
| 92 | regulation of cholesterol esterification (GO:0010872) | 3.58000227 |
| 93 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.56241475 |
| 94 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 3.55665626 |
| 95 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 3.55665626 |
| 96 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 3.55665626 |
| 97 | homocysteine metabolic process (GO:0050667) | 3.53036502 |
| 98 | regulation of triglyceride catabolic process (GO:0010896) | 3.52872550 |
| 99 | pyrimidine nucleoside salvage (GO:0043097) | 3.52721940 |
| 100 | pyrimidine-containing compound salvage (GO:0008655) | 3.52721940 |
| 101 | respiratory electron transport chain (GO:0022904) | 3.52297110 |
| 102 | desmosome organization (GO:0002934) | 3.51603153 |
| 103 | ethanol oxidation (GO:0006069) | 3.51188705 |
| 104 | sulfation (GO:0051923) | 3.48024590 |
| 105 | bicarbonate transport (GO:0015701) | 3.47379151 |
| 106 | adhesion of symbiont to host (GO:0044406) | 3.46457311 |
| 107 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.43725864 |
| 108 | electron transport chain (GO:0022900) | 3.41618315 |
| 109 | positive regulation of epidermis development (GO:0045684) | 3.41334954 |
| 110 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.40688968 |
| 111 | oxidative phosphorylation (GO:0006119) | 3.39267200 |
| 112 | regulation of pseudopodium assembly (GO:0031272) | 3.39148267 |
| 113 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.38285092 |
| 114 | phospholipid efflux (GO:0033700) | 3.37479537 |
| 115 | glomerular filtration (GO:0003094) | 3.34731526 |
| 116 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 3.33736497 |
| 117 | O-glycan processing (GO:0016266) | 3.33158474 |
| 118 | glucose 6-phosphate metabolic process (GO:0051156) | 3.33149310 |
| 119 | nucleoside salvage (GO:0043174) | 3.32770027 |
| 120 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.31559071 |
| 121 | positive regulation of lipid catabolic process (GO:0050996) | 3.28646984 |
| 122 | drug transport (GO:0015893) | 3.26514790 |
| 123 | bile acid metabolic process (GO:0008206) | 3.24756239 |
| 124 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.22411883 |
| 125 | auditory receptor cell differentiation (GO:0042491) | 3.22174167 |
| 126 | oligosaccharide biosynthetic process (GO:0009312) | 3.21492087 |
| 127 | membrane repolarization during action potential (GO:0086011) | 3.21216799 |
| 128 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.19860449 |
| 129 | regulation of cholesterol homeostasis (GO:2000188) | 3.15829723 |
| 130 | sodium ion homeostasis (GO:0055078) | 3.13784313 |
| 131 | keratinocyte proliferation (GO:0043616) | 3.13272022 |
| 132 | lipoprotein metabolic process (GO:0042157) | 3.13000531 |
| 133 | drinking behavior (GO:0042756) | 3.12749173 |
| 134 | negative regulation of epidermis development (GO:0045683) | 3.12657272 |
| 135 | glycosylceramide metabolic process (GO:0006677) | 3.12606469 |
| 136 | vitamin transport (GO:0051180) | 3.12015959 |
| 137 | cGMP biosynthetic process (GO:0006182) | 3.11743853 |
| 138 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.11315521 |
| 139 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.10337735 |
| 140 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.08975068 |
| 141 | sperm capacitation (GO:0048240) | 3.08676698 |
| 142 | ribonucleoside bisphosphate metabolic process (GO:0033875) | 3.06973532 |
| 143 | nucleoside bisphosphate metabolic process (GO:0033865) | 3.06973532 |
| 144 | purine nucleoside bisphosphate metabolic process (GO:0034032) | 3.06973532 |
| 145 | glycerol metabolic process (GO:0006071) | 3.05591777 |
| 146 | arginine metabolic process (GO:0006525) | 3.05297033 |
| 147 | sphingomyelin metabolic process (GO:0006684) | 3.05152043 |
| 148 | epithelial cell-cell adhesion (GO:0090136) | 3.05148643 |
| 149 | ceramide catabolic process (GO:0046514) | 3.05042317 |
| 150 | plasma lipoprotein particle organization (GO:0071827) | 3.02073244 |
| 151 | exogenous drug catabolic process (GO:0042738) | 3.01340465 |
| 152 | renal filtration (GO:0097205) | 3.01168707 |
| 153 | sphingolipid catabolic process (GO:0030149) | 2.99944371 |
| 154 | ATP biosynthetic process (GO:0006754) | 2.98080259 |
| 155 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.96823213 |
| 156 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.95832509 |
| 157 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.92151747 |
| 158 | mitotic G2/M transition checkpoint (GO:0044818) | 2.91866278 |
| 159 | drug transmembrane transport (GO:0006855) | 2.90146142 |
| 160 | transcytosis (GO:0045056) | 2.89549216 |
| 161 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.88758890 |
| 162 | digestion (GO:0007586) | 2.88635380 |
| 163 | virion attachment to host cell (GO:0019062) | 2.88139250 |
| 164 | adhesion of symbiont to host cell (GO:0044650) | 2.88139250 |
| 165 | somite development (GO:0061053) | 2.87347897 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.68323103 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.38723866 |
| 3 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 4.08584109 |
| 4 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.99072446 |
| 5 | GATA4_25053715_ChIP-Seq_YYC3_Human | 3.21832723 |
| 6 | SOX2_20726797_ChIP-Seq_SW620_Human | 3.18505372 |
| 7 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 3.04308793 |
| 8 | GATA6_25053715_ChIP-Seq_YYC3_Human | 3.00185454 |
| 9 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.79116966 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.69440046 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.57133797 |
| 12 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.53530287 |
| 13 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.36784289 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.26343351 |
| 15 | VDR_22108803_ChIP-Seq_LS180_Human | 2.25740757 |
| 16 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.15380615 |
| 17 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.05857902 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.01927614 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 10.8357761 |
| 20 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.99756949 |
| 21 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.94276800 |
| 22 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.94051403 |
| 23 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.92624868 |
| 24 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.92490752 |
| 25 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.92250538 |
| 26 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.91442155 |
| 27 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.90798034 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.88841170 |
| 29 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.87067342 |
| 30 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.84844061 |
| 31 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.83290160 |
| 32 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.77694666 |
| 33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.74004904 |
| 34 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.69309503 |
| 35 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.68282215 |
| 36 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.68098930 |
| 37 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.65868868 |
| 38 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.55678056 |
| 39 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55094882 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.52694359 |
| 41 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.52447423 |
| 42 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.52382448 |
| 43 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.49414750 |
| 44 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.43867841 |
| 45 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.43438348 |
| 46 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.40030045 |
| 47 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39173584 |
| 48 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38102621 |
| 49 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.37285028 |
| 50 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.33541932 |
| 51 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.31630742 |
| 52 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.31558576 |
| 53 | ATF3_27146783_Chip-Seq_COLON_Human | 1.31502516 |
| 54 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29479158 |
| 55 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25737040 |
| 56 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.24847722 |
| 57 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.21464808 |
| 58 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18357761 |
| 59 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14310869 |
| 60 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.14258958 |
| 61 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12995421 |
| 62 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.11256949 |
| 63 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11128064 |
| 64 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.10631548 |
| 65 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.10457749 |
| 66 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.09736298 |
| 67 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.08381546 |
| 68 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08329470 |
| 69 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.07833850 |
| 70 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.07745458 |
| 71 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.06416600 |
| 72 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03966272 |
| 73 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.03039773 |
| 74 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.02638391 |
| 75 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.02577680 |
| 76 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.02400360 |
| 77 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.01613121 |
| 78 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.01170474 |
| 79 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.00965339 |
| 80 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.00661340 |
| 81 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00601019 |
| 82 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.99548293 |
| 83 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.99548293 |
| 84 | SA1_27219007_Chip-Seq_Bcells_Human | 0.98885764 |
| 85 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.97003479 |
| 86 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96869411 |
| 87 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.94649348 |
| 88 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.93714831 |
| 89 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90371260 |
| 90 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.89599568 |
| 91 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.87845248 |
| 92 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87222387 |
| 93 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86591307 |
| 94 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.86584352 |
| 95 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.86185291 |
| 96 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.86072325 |
| 97 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.85777565 |
| 98 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.85465022 |
| 99 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.84853098 |
| 100 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.83419936 |
| 101 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.83419777 |
| 102 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.83139508 |
| 103 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.83131014 |
| 104 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82426244 |
| 105 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.82396597 |
| 106 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.82191110 |
| 107 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.82140750 |
| 108 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.81588385 |
| 109 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.80871016 |
| 110 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80283364 |
| 111 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.79834090 |
| 112 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79811060 |
| 113 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.79023176 |
| 114 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.78733305 |
| 115 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.78293093 |
| 116 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77537360 |
| 117 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.76927921 |
| 118 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.76234773 |
| 119 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.74724212 |
| 120 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.74682087 |
| 121 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.74181417 |
| 122 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.73853129 |
| 123 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.71927655 |
| 124 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.71340640 |
| 125 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.71151955 |
| 126 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.70709731 |
| 127 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.70404598 |
| 128 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.70027815 |
| 129 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69905271 |
| 130 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.68758122 |
| 131 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.67921360 |
| 132 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.67901400 |
| 133 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.67277986 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 7.28545973 |
| 2 | MP0003283_abnormal_digestive_organ | 5.71749300 |
| 3 | MP0005360_urolithiasis | 5.48172946 |
| 4 | MP0000462_abnormal_digestive_system | 4.65327112 |
| 5 | MP0001666_abnormal_nutrient_absorption | 4.59479612 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.20585965 |
| 7 | MP0003866_abnormal_defecation | 2.97564279 |
| 8 | MP0004264_abnormal_extraembryonic_tissu | 2.83936741 |
| 9 | MP0009379_abnormal_foot_pigmentation | 2.71853457 |
| 10 | MP0008004_abnormal_stomach_pH | 2.68057186 |
| 11 | MP0002822_catalepsy | 2.65138375 |
| 12 | MP0005381_digestive/alimentary_phenotyp | 2.59030550 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.55791572 |
| 14 | MP0000490_abnormal_crypts_of | 2.54541792 |
| 15 | MP0001873_stomach_inflammation | 2.52876340 |
| 16 | MP0010155_abnormal_intestine_physiology | 2.49115346 |
| 17 | MP0001663_abnormal_digestive_system | 2.42082537 |
| 18 | MP0008875_abnormal_xenobiotic_pharmacok | 2.40839928 |
| 19 | MP0003315_abnormal_perineum_morphology | 2.39781221 |
| 20 | MP0009053_abnormal_anal_canal | 2.34632679 |
| 21 | MP0005409_darkened_coat_color | 2.23795114 |
| 22 | MP0003252_abnormal_bile_duct | 2.19454260 |
| 23 | MP0000477_abnormal_intestine_morphology | 2.18592082 |
| 24 | MP0002234_abnormal_pharynx_morphology | 2.16751094 |
| 25 | MP0005377_hearing/vestibular/ear_phenot | 2.15760235 |
| 26 | MP0003878_abnormal_ear_physiology | 2.15760235 |
| 27 | MP0004019_abnormal_vitamin_homeostasis | 2.03138894 |
| 28 | MP0005084_abnormal_gallbladder_morpholo | 1.98445634 |
| 29 | MP0005365_abnormal_bile_salt | 1.97378927 |
| 30 | MP0000537_abnormal_urethra_morphology | 1.95552228 |
| 31 | MP0001664_abnormal_digestion | 1.90174181 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.72886151 |
| 33 | MP0000613_abnormal_salivary_gland | 1.58384820 |
| 34 | MP0005670_abnormal_white_adipose | 1.52320174 |
| 35 | MP0010329_abnormal_lipoprotein_level | 1.45401877 |
| 36 | MP0009840_abnormal_foam_cell | 1.45069859 |
| 37 | MP0002132_abnormal_respiratory_system | 1.39259548 |
| 38 | MP0002796_impaired_skin_barrier | 1.37965088 |
| 39 | MP0001764_abnormal_homeostasis | 1.32500007 |
| 40 | MP0002876_abnormal_thyroid_physiology | 1.31040352 |
| 41 | MP0010678_abnormal_skin_adnexa | 1.26691422 |
| 42 | MP0001765_abnormal_ion_homeostasis | 1.24516389 |
| 43 | MP0004782_abnormal_surfactant_physiolog | 1.23264442 |
| 44 | MP0002098_abnormal_vibrissa_morphology | 1.22541639 |
| 45 | MP0003123_paternal_imprinting | 1.22306006 |
| 46 | MP0001188_hyperpigmentation | 1.21427673 |
| 47 | MP0004043_abnormal_pH_regulation | 1.20883738 |
| 48 | MP0004858_abnormal_nervous_system | 1.18658367 |
| 49 | MP0010352_gastrointestinal_tract_polyps | 1.15067691 |
| 50 | MP0000538_abnormal_urinary_bladder | 1.14469269 |
| 51 | MP0000470_abnormal_stomach_morphology | 1.12808863 |
| 52 | MP0009643_abnormal_urine_homeostasis | 1.12511525 |
| 53 | MP0003806_abnormal_nucleotide_metabolis | 1.11681860 |
| 54 | MP0003705_abnormal_hypodermis_morpholog | 1.09528595 |
| 55 | MP0008872_abnormal_physiological_respon | 1.09098311 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.04648058 |
| 57 | MP0002166_altered_tumor_susceptibility | 1.03236134 |
| 58 | MP0005636_abnormal_mineral_homeostasis | 1.00068284 |
| 59 | MP0000230_abnormal_systemic_arterial | 0.98712571 |
| 60 | MP0006054_spinal_hemorrhage | 0.96297955 |
| 61 | MP0000762_abnormal_tongue_morphology | 0.94318452 |
| 62 | MP0001485_abnormal_pinna_reflex | 0.92985818 |
| 63 | MP0004947_skin_inflammation | 0.90697043 |
| 64 | MP0004270_analgesia | 0.90488934 |
| 65 | MP0003453_abnormal_keratinocyte_physiol | 0.90011535 |
| 66 | MP0003941_abnormal_skin_development | 0.89688492 |
| 67 | MP0003868_abnormal_feces_composition | 0.89634566 |
| 68 | MP0001756_abnormal_urination | 0.87674489 |
| 69 | MP0005319_abnormal_enzyme/_coenzyme | 0.87083720 |
| 70 | MP0002971_abnormal_brown_adipose | 0.85089093 |
| 71 | MP0005166_decreased_susceptibility_to | 0.84709447 |
| 72 | MP0000566_synostosis | 0.83104845 |
| 73 | MP0005451_abnormal_body_composition | 0.82659207 |
| 74 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.81548835 |
| 75 | MP0003693_abnormal_embryo_hatching | 0.81319306 |
| 76 | MP0003045_fibrosis | 0.81069604 |
| 77 | MP0005448_abnormal_energy_balance | 0.80555582 |
| 78 | MP0000678_abnormal_parathyroid_gland | 0.79911212 |
| 79 | MP0002009_preneoplasia | 0.79211732 |
| 80 | MP0004484_altered_response_of | 0.77555745 |
| 81 | MP0001845_abnormal_inflammatory_respons | 0.77072375 |
| 82 | MP0009115_abnormal_fat_cell | 0.73428985 |
| 83 | MP0003566_abnormal_cell_adhesion | 0.72141990 |
| 84 | MP0009642_abnormal_blood_homeostasis | 0.72008636 |
| 85 | MP0002006_tumorigenesis | 0.71631862 |
| 86 | MP0003718_maternal_effect | 0.71532795 |
| 87 | MP0000465_gastrointestinal_hemorrhage | 0.69568488 |
| 88 | MP0005666_abnormal_adipose_tissue | 0.68291380 |
| 89 | MP0000467_abnormal_esophagus_morphology | 0.67660827 |
| 90 | MP0005058_abnormal_lysosome_morphology | 0.67471111 |
| 91 | MP0005310_abnormal_salivary_gland | 0.67258587 |
| 92 | MP0005501_abnormal_skin_physiology | 0.66725215 |
| 93 | MP0003183_abnormal_peptide_metabolism | 0.66192303 |
| 94 | MP0002896_abnormal_bone_mineralization | 0.65013305 |
| 95 | MP0005535_abnormal_body_temperature | 0.64330501 |
| 96 | MP0004147_increased_porphyrin_level | 0.63938981 |
| 97 | MP0005167_abnormal_blood-brain_barrier | 0.63487335 |
| 98 | MP0009785_altered_susceptibility_to | 0.62402343 |
| 99 | MP0008469_abnormal_protein_level | 0.61426179 |
| 100 | MP0003787_abnormal_imprinting | 0.61196781 |
| 101 | MP0003953_abnormal_hormone_level | 0.61189568 |
| 102 | MP0003303_peritoneal_inflammation | 0.60619831 |
| 103 | MP0005332_abnormal_amino_acid | 0.60437338 |
| 104 | MP0002909_abnormal_adrenal_gland | 0.59240138 |
| 105 | MP0001216_abnormal_epidermal_layer | 0.58391574 |
| 106 | MP0009384_cardiac_valve_regurgitation | 0.56437935 |
| 107 | MP0000604_amyloidosis | 0.56393402 |
| 108 | MP0002118_abnormal_lipid_homeostasis | 0.56136941 |
| 109 | MP0002136_abnormal_kidney_physiology | 0.55751056 |
| 110 | MP0002078_abnormal_glucose_homeostasis | 0.54642196 |
| 111 | MP0002396_abnormal_hematopoietic_system | 0.53900654 |
| 112 | MP0002138_abnormal_hepatobiliary_system | 0.53492969 |
| 113 | MP0009333_abnormal_splenocyte_physiolog | 0.52319014 |
| 114 | MP0003329_amyloid_beta_deposits | 0.51775486 |
| 115 | MP0003879_abnormal_hair_cell | 0.51038855 |
| 116 | MP0005025_abnormal_response_to | 0.49917290 |
| 117 | MP0003724_increased_susceptibility_to | 0.49828687 |
| 118 | MP0000249_abnormal_blood_vessel | 0.48641174 |
| 119 | MP0003119_abnormal_digestive_system | 0.46341866 |
| 120 | MP0002254_reproductive_system_inflammat | 0.45671235 |
| 121 | MP0000609_abnormal_liver_physiology | 0.44571911 |
| 122 | MP0002089_abnormal_postnatal_growth/wei | 0.44189972 |
| 123 | MP0010386_abnormal_urinary_bladder | 0.43826373 |
| 124 | MP0005334_abnormal_fat_pad | 0.43120048 |
| 125 | MP0001881_abnormal_mammary_gland | 0.42894246 |
| 126 | MP0002282_abnormal_trachea_morphology | 0.42770393 |
| 127 | MP0002928_abnormal_bile_duct | 0.42601059 |
| 128 | MP0000049_abnormal_middle_ear | 0.42506744 |
| 129 | MP0004215_abnormal_myocardial_fiber | 0.41831818 |
| 130 | MP0004957_abnormal_blastocyst_morpholog | 0.41511776 |
| 131 | MP0001501_abnormal_sleep_pattern | 0.41198410 |
| 132 | MP0002060_abnormal_skin_morphology | 0.40536576 |
| 133 | MP0000377_abnormal_hair_follicle | 0.40304430 |
| 134 | MP0002932_abnormal_joint_morphology | 0.40165031 |
| 135 | MP0000163_abnormal_cartilage_morphology | 0.39501705 |
| 136 | MP0003191_abnormal_cellular_cholesterol | 0.35890237 |
| 137 | MP0004272_abnormal_basement_membrane | 0.35256037 |
| 138 | MP0001849_ear_inflammation | 0.34691928 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Posterior subcapsular cataract (HP:0007787) | 6.46871894 |
| 2 | Ileus (HP:0002595) | 6.17072430 |
| 3 | Abnormality of proline metabolism (HP:0010907) | 5.98931353 |
| 4 | Hydroxyprolinuria (HP:0003080) | 5.98931353 |
| 5 | Hyperactive renin-angiotensin system (HP:0000841) | 5.84220385 |
| 6 | Flat acetabular roof (HP:0003180) | 5.81270265 |
| 7 | Decreased circulating renin level (HP:0003351) | 5.04825081 |
| 8 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 4.87142567 |
| 9 | Neonatal short-limb short stature (HP:0008921) | 4.65221308 |
| 10 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 4.47113381 |
| 11 | Pustule (HP:0200039) | 4.44934454 |
| 12 | Cupped ribs (HP:0000887) | 4.44074882 |
| 13 | Abnormality of renin-angiotensin system (HP:0000847) | 4.43355083 |
| 14 | Abnormality of the 1st metacarpal (HP:0010009) | 4.19670120 |
| 15 | Ventricular fibrillation (HP:0001663) | 4.02573164 |
| 16 | Alkalosis (HP:0001948) | 3.98042125 |
| 17 | Flat capital femoral epiphysis (HP:0003370) | 3.87798232 |
| 18 | Flattened epiphyses (HP:0003071) | 3.76641658 |
| 19 | Subcapsular cataract (HP:0000523) | 3.73780010 |
| 20 | Large earlobe (HP:0009748) | 3.70400102 |
| 21 | Right ventricular cardiomyopathy (HP:0011663) | 3.66440139 |
| 22 | Biliary tract neoplasm (HP:0100574) | 3.62463122 |
| 23 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.61467611 |
| 24 | Systemic lupus erythematosus (HP:0002725) | 3.61451121 |
| 25 | Confusion (HP:0001289) | 3.59299737 |
| 26 | Abnormality of vitamin metabolism (HP:0100508) | 3.56492598 |
| 27 | Abnormality of carpal bone ossification (HP:0006257) | 3.54478244 |
| 28 | Abdominal distention (HP:0003270) | 3.42873973 |
| 29 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 3.39800563 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.36297571 |
| 31 | Ridged nail (HP:0001807) | 3.33120244 |
| 32 | Abnormal biliary tract morphology (HP:0012440) | 3.29940006 |
| 33 | Congenital sensorineural hearing impairment (HP:0008527) | 3.29848114 |
| 34 | Spinal cord compression (HP:0002176) | 3.29689609 |
| 35 | Irregular epiphyses (HP:0010582) | 3.26595904 |
| 36 | Pigmentary retinal degeneration (HP:0001146) | 3.23999136 |
| 37 | Breech presentation (HP:0001623) | 3.21937599 |
| 38 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.16158363 |
| 39 | Hyperglycinuria (HP:0003108) | 3.14675104 |
| 40 | Hemorrhage of the eye (HP:0011885) | 3.13834531 |
| 41 | Proximal tubulopathy (HP:0000114) | 3.10320596 |
| 42 | Vertebral hypoplasia (HP:0008417) | 3.06563329 |
| 43 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 3.06563329 |
| 44 | Abnormal cartilage morphology (HP:0002763) | 2.99988273 |
| 45 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.96878409 |
| 46 | Xanthomatosis (HP:0000991) | 2.96870896 |
| 47 | Nausea (HP:0002018) | 2.96836749 |
| 48 | Malnutrition (HP:0004395) | 2.95847384 |
| 49 | Abnormal tarsal ossification (HP:0008369) | 2.95729811 |
| 50 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.93761941 |
| 51 | Short phalanx of the thumb (HP:0009660) | 2.90588354 |
| 52 | Woolly hair (HP:0002224) | 2.87934770 |
| 53 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.87282707 |
| 54 | Hyperparathyroidism (HP:0000843) | 2.86560772 |
| 55 | Increased hepatocellular lipid droplets (HP:0006565) | 2.84340452 |
| 56 | Lipid accumulation in hepatocytes (HP:0006561) | 2.83325557 |
| 57 | Nephrolithiasis (HP:0000787) | 2.81544579 |
| 58 | Hyperaldosteronism (HP:0000859) | 2.81201665 |
| 59 | Visceral angiomatosis (HP:0100761) | 2.78759270 |
| 60 | Fragile nails (HP:0001808) | 2.76952391 |
| 61 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.71859591 |
| 62 | Abnormality of glycine metabolism (HP:0010895) | 2.71859591 |
| 63 | Neoplasm of the rectum (HP:0100743) | 2.69243531 |
| 64 | Vertebral clefting (HP:0008428) | 2.69054038 |
| 65 | Breast hypoplasia (HP:0003187) | 2.66169453 |
| 66 | Acanthocytosis (HP:0001927) | 2.64619815 |
| 67 | Abnormal ossification of hand bones (HP:0005921) | 2.64294806 |
| 68 | Hypolipoproteinemia (HP:0010981) | 2.63566476 |
| 69 | Hyperammonemia (HP:0001987) | 2.63023137 |
| 70 | Widely patent fontanelles and sutures (HP:0004492) | 2.62329374 |
| 71 | Abnormal vertebral ossification (HP:0100569) | 2.61827402 |
| 72 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.61281959 |
| 73 | Short middle phalanx of finger (HP:0005819) | 2.61124338 |
| 74 | Abnormal hand bone ossification (HP:0010660) | 2.60959555 |
| 75 | Cheilitis (HP:0100825) | 2.59980703 |
| 76 | Hypophosphatemia (HP:0002148) | 2.59199331 |
| 77 | Hyperphosphaturia (HP:0003109) | 2.58819853 |
| 78 | Hypotension (HP:0002615) | 2.57456457 |
| 79 | Hyperuricemia (HP:0002149) | 2.54903477 |
| 80 | Increased purine levels (HP:0004368) | 2.54903477 |
| 81 | Hemangiomatosis (HP:0007461) | 2.54403854 |
| 82 | Glycosuria (HP:0003076) | 2.50921976 |
| 83 | Abnormality of urine glucose concentration (HP:0011016) | 2.50921976 |
| 84 | Hypobetalipoproteinemia (HP:0003563) | 2.50114574 |
| 85 | Hypokalemia (HP:0002900) | 2.48823475 |
| 86 | Micronodular cirrhosis (HP:0001413) | 2.48007136 |
| 87 | Potter facies (HP:0002009) | 2.47496105 |
| 88 | Facial shape deformation (HP:0011334) | 2.47496105 |
| 89 | Chronic diarrhea (HP:0002028) | 2.47371909 |
| 90 | Symptomatic seizures (HP:0011145) | 2.43608254 |
| 91 | Abnormal hemoglobin (HP:0011902) | 2.43600414 |
| 92 | Acute encephalopathy (HP:0006846) | 2.43362189 |
| 93 | Steatorrhea (HP:0002570) | 2.42841847 |
| 94 | Neoplasm of the small intestine (HP:0100833) | 2.42271572 |
| 95 | Megaloblastic anemia (HP:0001889) | 2.41966040 |
| 96 | Increased intramyocellular lipid droplets (HP:0012240) | 2.41927212 |
| 97 | Abnormality of the 2nd finger (HP:0004100) | 2.39198833 |
| 98 | Enlarged epiphyses (HP:0010580) | 2.37943733 |
| 99 | Cone-rod dystrophy (HP:0000548) | 2.36711216 |
| 100 | Delayed epiphyseal ossification (HP:0002663) | 2.35910806 |
| 101 | Focal segmental glomerulosclerosis (HP:0000097) | 2.34807481 |
| 102 | Mitochondrial inheritance (HP:0001427) | 2.34329019 |
| 103 | Increased muscle lipid content (HP:0009058) | 2.33473207 |
| 104 | Hypoplastic ilia (HP:0000946) | 2.32210522 |
| 105 | Alopecia of scalp (HP:0002293) | 2.31447648 |
| 106 | Fat malabsorption (HP:0002630) | 2.29770056 |
| 107 | Hyperphosphatemia (HP:0002905) | 2.29080609 |
| 108 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.28904328 |
| 109 | Thin bony cortex (HP:0002753) | 2.28885162 |
| 110 | Hip contracture (HP:0003273) | 2.27334916 |
| 111 | Abnormality of potassium homeostasis (HP:0011042) | 2.27317619 |
| 112 | Hyponatremia (HP:0002902) | 2.26133384 |
| 113 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.25956500 |
| 114 | Renal tubular acidosis (HP:0001947) | 2.25564330 |
| 115 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.20073451 |
| 116 | Short tibia (HP:0005736) | 2.18911061 |
| 117 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.18323555 |
| 118 | Dicarboxylic aciduria (HP:0003215) | 2.18323555 |
| 119 | Abnormality of purine metabolism (HP:0004352) | 2.18221345 |
| 120 | Progressive macrocephaly (HP:0004481) | 2.17959556 |
| 121 | Abnormal urine phosphate concentration (HP:0012599) | 2.17622227 |
| 122 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.17065700 |
| 123 | Absent phalangeal crease (HP:0006109) | 2.16636897 |
| 124 | Gout (HP:0001997) | 2.13256566 |
| 125 | Wide cranial sutures (HP:0010537) | 2.13099233 |
| 126 | Glomerulonephritis (HP:0000099) | 2.12827380 |
| 127 | Late onset (HP:0003584) | 2.12678094 |
| 128 | Gastrointestinal dysmotility (HP:0002579) | 2.12151337 |
| 129 | Abnormality of vitamin B metabolism (HP:0004340) | 2.11713689 |
| 130 | Protuberant abdomen (HP:0001538) | 2.11364937 |
| 131 | Tracheal stenosis (HP:0002777) | 2.09858226 |
| 132 | Eczematoid dermatitis (HP:0000976) | 2.09659054 |
| 133 | Fragile skin (HP:0001030) | 2.07708657 |
| 134 | Pterygium (HP:0001059) | 2.07167691 |
| 135 | Abnormality of the costochondral junction (HP:0000919) | 2.07111115 |
| 136 | Abnormality of chloride homeostasis (HP:0011422) | 2.06852121 |
| 137 | Metabolic alkalosis (HP:0200114) | 2.06025521 |
| 138 | Acute necrotizing encephalopathy (HP:0006965) | 2.05664946 |
| 139 | Pili torti (HP:0003777) | 2.05470290 |
| 140 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.05094842 |
| 141 | Villous atrophy (HP:0011473) | 2.05094842 |
| 142 | Abnormality of magnesium homeostasis (HP:0004921) | 2.04689368 |
| 143 | Metabolic acidosis (HP:0001942) | 2.04116355 |
| 144 | Complement deficiency (HP:0004431) | 2.03840396 |
| 145 | Hoarse voice (HP:0001609) | 2.03057710 |
| 146 | Hypoglycemic coma (HP:0001325) | 2.02933512 |
| 147 | Abnormality of nucleobase metabolism (HP:0010932) | 2.02561935 |
| 148 | Exertional dyspnea (HP:0002875) | 2.02525333 |
| 149 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.02049935 |
| 150 | Ankyloglossia (HP:0010296) | 2.01899451 |
| 151 | Subacute progressive viral hepatitis (HP:0006572) | 2.01236879 |
| 152 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.00065169 |
| 153 | Growth hormone excess (HP:0000845) | 2.00024083 |
| 154 | Rectal prolapse (HP:0002035) | 1.99376644 |
| 155 | Cerebral palsy (HP:0100021) | 1.98821779 |
| 156 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.98539099 |
| 157 | Intrahepatic cholestasis (HP:0001406) | 1.98256645 |
| 158 | Abnormality of complement system (HP:0005339) | 1.97766514 |
| 159 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.97707952 |
| 160 | Dehydration (HP:0001944) | 1.95125122 |
| 161 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.89394825 |
| 162 | Epidermoid cyst (HP:0200040) | 1.86987534 |
| 163 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.84404810 |
| 164 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.82623751 |
| 165 | Nephritis (HP:0000123) | 1.81632763 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 7.29204658 |
| 2 | LMTK2 | 4.70668310 |
| 3 | EPHB2 | 4.58981354 |
| 4 | ERN1 | 3.91037562 |
| 5 | FRK | 3.84625119 |
| 6 | PRKG2 | 2.95713559 |
| 7 | PIK3CA | 2.48090418 |
| 8 | MST4 | 2.46248791 |
| 9 | FGFR4 | 2.40566433 |
| 10 | RIPK1 | 2.29489378 |
| 11 | MST1R | 2.03213153 |
| 12 | TAOK3 | 11.4014445 |
| 13 | MAP2K2 | 1.96052676 |
| 14 | NME1 | 1.95407260 |
| 15 | NUAK1 | 1.94027618 |
| 16 | TTK | 1.79197135 |
| 17 | GRK6 | 1.77401957 |
| 18 | PBK | 1.77383365 |
| 19 | PDK2 | 1.73355960 |
| 20 | FGFR3 | 1.47756526 |
| 21 | TAOK1 | 1.47220988 |
| 22 | MYLK | 1.42964591 |
| 23 | EIF2AK1 | 1.30557141 |
| 24 | TYK2 | 1.27332882 |
| 25 | STK24 | 1.26416514 |
| 26 | PTK6 | 1.26251706 |
| 27 | MAP3K2 | 1.22448744 |
| 28 | KSR2 | 1.21728318 |
| 29 | TESK1 | 1.18718485 |
| 30 | PRPF4B | 1.16958932 |
| 31 | MAP2K6 | 1.14420323 |
| 32 | NEK2 | 1.10118198 |
| 33 | EPHA3 | 1.03991589 |
| 34 | AURKB | 1.03449687 |
| 35 | MAP3K9 | 1.03198685 |
| 36 | MAP4K1 | 0.96924763 |
| 37 | EPHA2 | 0.94625532 |
| 38 | TRIB3 | 0.92224735 |
| 39 | EPHB1 | 0.90777524 |
| 40 | SMG1 | 0.90687027 |
| 41 | TNIK | 0.90354386 |
| 42 | ERBB2 | 0.86968249 |
| 43 | PDK1 | 0.75544892 |
| 44 | PTK2 | 0.70846396 |
| 45 | DDR2 | 0.68887177 |
| 46 | PDGFRA | 0.68231478 |
| 47 | DYRK1B | 0.67517363 |
| 48 | TESK2 | 0.67444387 |
| 49 | MATK | 0.67028456 |
| 50 | EPHA4 | 0.64799771 |
| 51 | IRAK3 | 0.63331202 |
| 52 | NLK | 0.62412089 |
| 53 | PRKCI | 0.60027316 |
| 54 | STK39 | 0.58828133 |
| 55 | MAP2K1 | 0.58747279 |
| 56 | CASK | 0.57574543 |
| 57 | RET | 0.55626732 |
| 58 | RIPK4 | 0.55490989 |
| 59 | CAMK2D | 0.54931090 |
| 60 | MAP3K11 | 0.54417023 |
| 61 | PRKAA2 | 0.54004503 |
| 62 | MAP3K12 | 0.53958905 |
| 63 | MAP3K8 | 0.53011334 |
| 64 | MAP3K13 | 0.52755541 |
| 65 | MAP3K14 | 0.50916105 |
| 66 | PIK3CG | 0.50910630 |
| 67 | ARAF | 0.48413933 |
| 68 | CDK19 | 0.47154367 |
| 69 | GRK1 | 0.46857338 |
| 70 | PAK4 | 0.45928268 |
| 71 | ILK | 0.44084207 |
| 72 | PRKCZ | 0.43575116 |
| 73 | PAK1 | 0.43400259 |
| 74 | ICK | 0.43137401 |
| 75 | LIMK1 | 0.42266723 |
| 76 | MAP3K10 | 0.40421593 |
| 77 | CAMK2B | 0.39820253 |
| 78 | AKT3 | 0.39501587 |
| 79 | ABL2 | 0.37913486 |
| 80 | PASK | 0.37795338 |
| 81 | PIM1 | 0.36756598 |
| 82 | FYN | 0.36072292 |
| 83 | PKN2 | 0.35607579 |
| 84 | PLK1 | 0.33486197 |
| 85 | TBK1 | 0.33468247 |
| 86 | CAMK2G | 0.33423285 |
| 87 | IRAK1 | 0.32054381 |
| 88 | BMPR2 | 0.32051614 |
| 89 | PRKCA | 0.32000376 |
| 90 | JAK1 | 0.31188546 |
| 91 | OXSR1 | 0.30831919 |
| 92 | JAK2 | 0.30417339 |
| 93 | STK11 | 0.29778445 |
| 94 | MET | 0.29363135 |
| 95 | MAPK11 | 0.29225802 |
| 96 | CSF1R | 0.27578727 |
| 97 | TLK1 | 0.26688735 |
| 98 | MAP3K1 | 0.26443982 |
| 99 | EEF2K | 0.26103689 |
| 100 | SRC | 0.25704465 |
| 101 | PRKCD | 0.25182634 |
| 102 | BRAF | 0.24373467 |
| 103 | MAPKAPK5 | 0.22845913 |
| 104 | DAPK2 | 0.21253345 |
| 105 | MAPKAPK2 | 0.20622584 |
| 106 | STK3 | 0.20175245 |
| 107 | YES1 | 0.19571699 |
| 108 | CHEK2 | 0.19281037 |
| 109 | NEK6 | 0.18576159 |
| 110 | LYN | 0.18033875 |
| 111 | CDK6 | 0.17227782 |
| 112 | MELK | 0.15792588 |
| 113 | RPS6KA2 | 0.15278705 |
| 114 | ROCK1 | 0.14842033 |
| 115 | IGF1R | 0.14742079 |
| 116 | IKBKE | 0.14451337 |
| 117 | PRKAA1 | 0.13770517 |
| 118 | MAP3K3 | 0.13761464 |
| 119 | KSR1 | 0.13630586 |
| 120 | EIF2AK2 | 0.13086052 |
| 121 | ALK | 0.12785341 |
| 122 | CDC42BPA | 0.12692481 |
| 123 | PRKCQ | 0.12517402 |
| 124 | PRKACG | 0.12462849 |
| 125 | FER | 0.12443936 |
| 126 | WNK4 | 0.12398860 |
| 127 | RPS6KB2 | 0.12201207 |
| 128 | ITK | 0.10707222 |
| 129 | CDK15 | 0.10022431 |
| 130 | CSK | 0.09503863 |
| 131 | CDK11A | 0.09321816 |
| 132 | NEK1 | 0.08757684 |
| 133 | LATS1 | 0.08172914 |
| 134 | PDPK1 | 0.07916682 |
| 135 | CDK18 | 0.07706151 |
| 136 | BMX | 0.07649918 |
| 137 | PRKD2 | 0.07241945 |
| 138 | AKT2 | 0.06501641 |
| 139 | STK10 | 0.06307579 |
| 140 | PRKCB | 0.06101303 |
| 141 | CSNK1E | 0.05580927 |
| 142 | CDK7 | 0.05405708 |
| 143 | CSNK1A1 | 0.05003684 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 5.09512636 |
| 2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.09738049 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.03405592 |
| 4 | Mineral absorption_Homo sapiens_hsa04978 | 3.60813736 |
| 5 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.91148987 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.86811069 |
| 7 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.73889971 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.38453638 |
| 9 | Bile secretion_Homo sapiens_hsa04976 | 2.33939278 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.24454221 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 2.06511679 |
| 12 | Galactose metabolism_Homo sapiens_hsa00052 | 2.03517137 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.03203238 |
| 14 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.99077001 |
| 15 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.95968383 |
| 16 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.93589544 |
| 17 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.90248924 |
| 18 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.76995757 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.76421520 |
| 20 | Alzheimers disease_Homo sapiens_hsa05010 | 1.73812929 |
| 21 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.62526978 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.59149140 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.50802355 |
| 24 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.48822100 |
| 25 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.44175805 |
| 26 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.43613689 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.43205573 |
| 28 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.41263910 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.36894714 |
| 30 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.33228196 |
| 31 | Huntingtons disease_Homo sapiens_hsa05016 | 1.30095244 |
| 32 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.29500968 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.28902511 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.28233916 |
| 35 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.26599074 |
| 36 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.25571791 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.20113164 |
| 38 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.17640550 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.16055869 |
| 40 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.14740212 |
| 41 | Tight junction_Homo sapiens_hsa04530 | 1.10636835 |
| 42 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.10434874 |
| 43 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.98931198 |
| 44 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.98039475 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96832481 |
| 46 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.93355090 |
| 47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.91751723 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90381659 |
| 49 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.83183014 |
| 50 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.82691029 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 0.80758832 |
| 52 | Ribosome_Homo sapiens_hsa03010 | 0.79591752 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.79559432 |
| 54 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.79546581 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79538453 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 0.78924240 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 0.77775656 |
| 58 | Asthma_Homo sapiens_hsa05310 | 0.77732907 |
| 59 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.76947075 |
| 60 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.76227593 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75343956 |
| 62 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.71423291 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 0.70458515 |
| 64 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.67095972 |
| 65 | Salivary secretion_Homo sapiens_hsa04970 | 0.66921429 |
| 66 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.66105566 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.63334280 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.60307477 |
| 69 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.59893753 |
| 70 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55139970 |
| 71 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.55093466 |
| 72 | Allograft rejection_Homo sapiens_hsa05330 | 0.53859650 |
| 73 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.53095148 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52695707 |
| 75 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.52268332 |
| 76 | Peroxisome_Homo sapiens_hsa04146 | 0.50342962 |
| 77 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.50288328 |
| 78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49796462 |
| 79 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.49068973 |
| 80 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.47896993 |
| 81 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.47392310 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46661168 |
| 83 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.46524027 |
| 84 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46026586 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45441480 |
| 86 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.45386143 |
| 87 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.45181769 |
| 88 | Renin secretion_Homo sapiens_hsa04924 | 0.45047440 |
| 89 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.44808462 |
| 90 | Retinol metabolism_Homo sapiens_hsa00830 | 0.44789351 |
| 91 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.40899507 |
| 92 | Salmonella infection_Homo sapiens_hsa05132 | 0.36727462 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.36105623 |
| 94 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35366465 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33638350 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.33222158 |
| 97 | Bladder cancer_Homo sapiens_hsa05219 | 0.31303228 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.31261697 |
| 99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.29657906 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27838693 |
| 101 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24639210 |
| 102 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.24606611 |
| 103 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.22966765 |
| 104 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.22934850 |
| 105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.22301546 |
| 106 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.21178665 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.18714336 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.17488147 |
| 109 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.17396483 |
| 110 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.17217223 |
| 111 | Thyroid cancer_Homo sapiens_hsa05216 | 0.15836368 |
| 112 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.15829409 |
| 113 | Cocaine addiction_Homo sapiens_hsa05030 | 0.15259196 |
| 114 | Gap junction_Homo sapiens_hsa04540 | 0.14923420 |
| 115 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.14437248 |
| 116 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.12729946 |
| 117 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.12141908 |
| 118 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.12131442 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.11802129 |
| 120 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.11754270 |
| 121 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.11385996 |
| 122 | Apoptosis_Homo sapiens_hsa04210 | 0.11097306 |
| 123 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.10917797 |
| 124 | Insulin secretion_Homo sapiens_hsa04911 | 0.10405414 |
| 125 | Leishmaniasis_Homo sapiens_hsa05140 | 0.09971470 |
| 126 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.09720481 |
| 127 | Pertussis_Homo sapiens_hsa05133 | 0.09310204 |
| 128 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.08685338 |
| 129 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.07520617 |
| 130 | Amoebiasis_Homo sapiens_hsa05146 | 0.06403870 |
| 131 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.05687953 |
| 132 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03314906 |
| 133 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.01234566 |

